[1]Lau WY, Lai ECH, Leung TWT.Current role of selective internalirradiation with yttrium-90 microspheres in the management ofhepatocellular carcinoma:a systematic review[J].Int J RadiatOncol Biol Phys, 2010 Sept 30[Epub ahead of print].
|
[2]Hilgard P, Muller S, Gerken G, et al.Radioembolizationwith yttrium-90 microspheres for hepatocellular carcinoma-methods and results[J].Eur Gastroenterol Hepatol Review, 2010, 6 (1) :82-89.
|
[3]Lau WY.Radiotherapy with emphasis on radio-embolizationfor liver tumours.In:Blumgart LH, Fong Y, editors.Surgeryof the Liver and Biliary Tract[M].Volume II, 2nd en.London:WB Saunders, 2000:1545-1564.
|
[4]Lau WY, Kennedy AS, Kim YH, et al.Patient selection andactivity planning guide for selective internal radiotherapywith yttrium-90 resin microspheres[J].Int J Radiat OncolBiol Phys, 2010 Oct 13[Epub ahead of print].
|
[5]Leung TWT, Lau WY, Ho SKW, et al.Radiation pneumonitis afterselective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatocellular carcinoma[J].Int JRadiat Oncol Biol Phys, 1995, 33 (4) :919-924.
|
[6]Inarrairaegui M, Thurston KG, Bilbao JI, et al.Radioembolization with use of yttrium-90 resin microspheresin patients with hepatocellular carcinoma and portal veinthrombosis[J].J Vas Interv Radiol, 2010, 21 (8) :1205-1212.
|
[7]Lau WY, Ho S, Leung TW, et al.Selective internal radiationtherapy for non-resectable hepatocellular carcinoma withintraarterial infusion of 90 yttrium microspheres[J].Int JRadiat Oncol Biol Phys, 1998, 40 (3) :583-592.
|
[8]Dancey JE, Shepherd FA, Paul K, et al.Treatment of non-resectable hepatocellular carcinoma with intrahepatic 90Y-microspheres[J].J Nucl Med, 2000, 41 (10) :1673-1681.
|
[9]Carr BI.Hepatic arterial 90 Yttrium glass microspheres (Therasphere) for unresectable heptocellular carcinoma:Interim safety and survival data on 65 patients[J].LiverTranspl, 2004, 10 (2 Suppl 1) :S107-S110.
|
[10]Geschwind JF, Salem R, Carr BI, et al.Yttrium-90microspheres for the treatment of hepatocellular carcinoma[J].Gastroenterology, 2004, 127 (5 Suppl 1) :S194-S205.
|
[11]Liu MD, Uaje MB, Al-Ghazi MS, et al.Use of yttrium-90ThereSphere for the treatment of unresectable hepatocellularcarcinoma[J].Am Surg, 2004, 70 (11) :947-953.
|
[12]Sangro B, Bibao JI, Boan J, et al.Radioembolizationusing 90Y-resin microspheres for patients with advancedhepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys, 2006, 66 (3) :792-800.
|
[13]Salem R, Lewandowski RJ, Atassi B, et al.Treatment ofunresectable hepatocellular carcinoma with use of 90Ymicrospheres (TheraSphere) :Safety, tumor response, andsurvival[J].J Vasc Interv Radiol, 2005, 16 (12) :1627-1639.
|
[14]Salem R, Lewandowski RJ, Mulcahy MF, et al.Radioembolizationfor hepatocellular carcinoma using Yttrium-90 microspheres:A comprehensive report of long-term outcomes[J].Gastroenterology, 2010, 138 (1) :52-64.
|
[15]Kulik LM, Carr Bi, Mulcahy MF, et al.Safety and efficacy of 90Yradiotherapy for hepatocellular carcinoma with and withoutportal vein thrombosis[J].Hepatology, 2008, 47 (1) :71-81.
|
[16]Heckman JT, Devera MB, Marsh JW, et al.Bridginglocoregional therapy for hepatocellular carcinoma prior to livertransplantation[J].Ann Surg Oncol, 2008, 15 (11) :3169-3177.
|
[17]Lau WY, Lai EC.Salvage surgery following downstaging ofunresectable hepatocellular carcinoma-a strategy to increaseresectability[J].Ann Surg Oncol, 2007, 14 (12) :3301-3309.
|
[18]Kulik LK, Atassi B, van Holsbeeck L, et al.Yttrium-90microspheres (TheraSphere) treatment of unresectablehepatocellular carcinoma:downstaging to resection, RFAand bridge to transplantation[J].J Surg Oncol, 2006, 94 (7) :572-586.
|
[19]Lewandowski RJ, Kulik LM, Riaz A, et al.A comparativeanalysis of transarterial downstaging for hepatocellularcarcinoma:Chemoembolization versus radioembolization[J].Am J Transpl, 2009, 9 (8) :1920-1928.
|
[20]Riaz A, Gates VL, Atassi B, et al.Radiation segmentectomy:A novel approach to increase safety and efficacy ofradioembolization[J].Int J Radiat Oncol Biol Phys, 2010 Apr24[Epub ahead of print].
|